Cara Therapeutics Inc (NASDAQ: CARA) Not A Good Play Anymore?
Cara Therapeutics Inc (CARA) concluded trading on Thursday at a closing price of $0.37, with 7.76 million shares of worth about $2.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.88% during that period and on July 11, 2024 the price saw a […]
Some Investing Thoughts On Cara Therapeutics Inc (NASDAQ: CARA)
Cara Therapeutics Inc (CARA) concluded trading on 12/28/23 at a closing price of $0.77, with 2.27 million shares of worth about $1.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.08% during that period and on Thursday the price saw a gain of […]
Growing Through Challenges? – Cara Therapeutics Inc (CARA)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Cara Therapeutics Inc (NASDAQ:CARA). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 2.56 million shares with purchase of 6024.0 shares. This fresh investment now brings its stake to 4.70% valued currently at $2.48 million. In addition, Disciplined […]
